Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma
- PMID: 11381040
Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma
Abstract
Purpose: To investigate the hypothesis that tumor-infiltrating macrophages contribute to prognosis of uveal melanoma and to study their association with tumor characteristics, especially microvessels.
Methods: This was a retrospective, population-based cohort study of 167 consecutive patients who had had an eye with choroidal and ciliary body melanoma removed between 1972 and 1981. Macrophages were identified with mAb PG-M1 to the CD68 epitope, and their number and morphologic type were recorded. Kaplan-Meier and Cox regression analyses of melanoma-specific survival were performed.
Results: CD68-positive macrophages could be assessed in 139 (83%) of the 167 melanomas. Their number was moderate to high in 115 (83%) of the 139 tumors, and their morphology ranged from dendritic to round. A high number of macrophages was associated with presence of epithelioid cells (P = 0.025), heavy pigmentation (P = 0.001), and high microvascular density (P = 0.001). The 10-year melanoma-specific mortality rate increased with higher numbers of macrophages (0.10 for low versus 0.57 for high numbers, P = 0.0012). The morphologic type of infiltrating macrophages was not associated with mortality. The number of macrophages was modeled by stratification, which significantly improved a Cox regression model (P < 0.001). Adjusting for the other independent indicators of metastatic death 10-year melanoma-specific mortality was 0.17 for low versus 0.45 for high numbers of macrophages.
Conclusions: The number of tumor-infiltrating CD68-positive macrophages contributes to prognosis and associates with cell type and microvascular density, which merits a further analysis of the biological role of these cells in uveal melanoma.
Similar articles
-
Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2442-9. Invest Ophthalmol Vis Sci. 2001. PMID: 11581181
-
Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2471-80. Invest Ophthalmol Vis Sci. 1999. PMID: 10509639
-
Detection of M2-macrophages in uveal melanoma and relation with survival.Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):643-50. doi: 10.1167/iovs.10-5979. Invest Ophthalmol Vis Sci. 2011. PMID: 20811059
-
Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?Prog Retin Eye Res. 2011 Mar;30(2):129-46. doi: 10.1016/j.preteyeres.2010.11.004. Epub 2010 Dec 1. Prog Retin Eye Res. 2011. PMID: 21129496 Review.
-
Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.Semin Ophthalmol. 2009 May-Jun;24(3):166-71. doi: 10.1080/08820530902805305. Semin Ophthalmol. 2009. PMID: 19437353 Review.
Cited by
-
Reduced expression of autotaxin predicts survival in uveal melanoma.Br J Ophthalmol. 2007 Oct;91(10):1385-92. doi: 10.1136/bjo.2007.116947. Epub 2007 May 2. Br J Ophthalmol. 2007. PMID: 17475713 Free PMC article.
-
Immune cells and angiogenesis.J Cell Mol Med. 2009 Sep;13(9A):2822-33. doi: 10.1111/j.1582-4934.2009.00810.x. Epub 2009 Jun 16. J Cell Mol Med. 2009. PMID: 19538473 Free PMC article. Review.
-
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?Cancers (Basel). 2019 Jun 17;11(6):834. doi: 10.3390/cancers11060834. Cancers (Basel). 2019. PMID: 31212986 Free PMC article. Review.
-
Expression of the metastasis suppressor BRMS1 in uveal melanoma.Ecancermedicalscience. 2014 Mar 11;8:410. doi: 10.3332/ecancer.2014.410. eCollection 2014. Ecancermedicalscience. 2014. PMID: 24688598 Free PMC article.
-
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.Oncotarget. 2015 Nov 10;6(35):37824-35. doi: 10.18632/oncotarget.5637. Oncotarget. 2015. PMID: 26462151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous